Meta-Analysis
Copyright ©The Author(s) 2020.
World J Gastroenterol. Jun 21, 2020; 26(23): 3304-3317
Published online Jun 21, 2020. doi: 10.3748/wjg.v26.i23.3304
Table 4 Summary diagnostic performance and subgroup analysis
CharacteristicsNo.SensitivitySpecificityPositive LRNegative LRDORAUC
LF ≥ F150.78 (0.73-0.82)0.81 (0.74-0.86)3.93 (2.12-7.27)0.30 (0.19-0.46)15.37 (5.74-41.16)0.862 (0.811-0.914)
LF ≥ F290.82 (0.79-0.86)0.80 (0.75-0.84)3.69 (2.53-5.37)0.24 (0.16-0.37)19.35 (9.51-39.34)0.883 (0.856-0.909)
LF ≥ F340.85 (0.79-0.90)0.83 (0.77-0.87)4.70 (3.51-6.28)0.21 (0.10-0.44)22.61 (8.24-62.05)0.886 (0.865-0.907)
LF = F460.90 (0.84-0.94)0.75 (0.70-0.79)3.36 (2.57-4.38)0.16 (0.08-0.31)26.99 (12.88-56.58)0.899 (0.866-0.932)
Subgroup analysis in LF ≥ F2
Study design
Retrospective60.86 (0.82-0.90)0.78 (0.71-0.83)3.73 (2.19-6.34)0.17 (0.10-0.29)29.82 (11.65-76.32)0.921 (0.891-0.952)
Prospective30.71 (0.62-0.79)0.84 (0.74-0.90)3.97 (2.42-6.52)0.42 (0.25-0.69)10.20 (4.30-24.16)0.905 (0.862-0.948)
Double blindness
Yes30.80 (0.74-0.85)0.75 (0.66-0.83)3.75 (1.69-8.32)0.25 (0.19-0.33)15.46 (8.20-29.14)0.874 (0.848-0.901)
Unclear60.85 (0.80-0.89)0.82 (0.76-0.87)3.80 (2.47-5.84)0.22 (0.10-0.49)22.39 (6.91-72.51)0.892 (0.855-0.930)
Field strength
1.5 T30.76 (0.68-0.83)0.81 (0.68-0.90)3.16 (1.67-5.99)0.34 (0.18-0.64)10.40 (3.51-30.87)0.839 (0.758-0.919)
3.0 T60.85 (0.81-0.89)0.79 (0.74-0.84)3.92 (2.42-6.37)0.19 (0.10-0.36)26.17 (10.81-63.36)0.904 (0.872-0.935)
Low b-values (0-50 s/mm2)
< 250.81 (0.75-0.86)0.81 (0.73-0.87)3.40 (2.17-5.35)0.26 (0.14-0.47)17.12 (6.11-47.98)0.877 (0.834-0.921)
≥ 240.83 (0.78-0.88)0.79 (0.72-0.85)4.11 (2.07-8.17)0.22 (0.10-0.47)21.73 (7.22-65.42)0.890 (0.855-0.935)
Trigger method
RT50.82 (0.77-0.86)0.79 (0.73-0.84)3.66 (2.24-5.97)0.27 (0.14-0.54)15.05 (5.78-39.22)0.867 (0.828-0.905)
Non-RT40.83 (0.77-0.88)0.81 (0.70-0.89)4.02 (1.85-8.76)0.21 (0.13-0.34)29.43 (9.89-87.59)0.919 (0.883-0.956)